Their stage IB subset analysis (1,371 patients) trended toward a benefit of adjuvant treatment (HR, 0.92) but failed to reach statistical significance (95% CI, 0.73-0.95).
← all excerpts
Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
1
—
—